Wall Street Journal: April 16, 2019. Due to lacking safety and effectiveness data, the FDA has ordered use of surgical mesh for pelvic organ prolapse in women to be stopped.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
FDA Stops Sales of Transvaginal Mesh for Pelvic Organ Prolapse
Drug Watch: April 16, 2019. The FDA has stopped the sales of transvaginal mesh for use in pelvic organ prolapse due to safety concerns.
Read More »FDA Progressive Device Approval Proposal Raises Eyebrows
MedTech Dive: April 16, 2019. The FDA’s device approval process’ standards are lowering, and we strongly oppose this radical new proposal.
Read More »Local Schools Waking Up to Student Sleep Needs
The Patriot Ledger: April 12, 2019. We explain why later start time of schools is better for teens’ health and performance.
Read More »Women on Female Viagra Can Now Drink Alcohol: FDA Removes Black Box Warning
The Daily Mail: April 12, 2019. We tell report what we think of Addyi: it’s expensive, often ineffective, and drinking alcohol with it can be problematic.
Read More »